This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,265.39 firm-fixed-price delivery order is for the supply of Methylphenidate transdermal patches, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 10, 2024 and does not have a set-aside designation. Amerisourcebergen, the prime contractor, is providing these medical supplies to support various federal healthcare programs and military treatment facilities nationwide through its extensive pharmaceutical distribution network. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for the broad supply of pharmaceutical and medical commodities to the Department of Defense and other federal agencies.
Generated 1/8/25, 9:18 AM